These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 14224011

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. REPORT ON TWENTY PATIENTS WITH MALIGNANT DISEASE TREATED WITH CYTOTOXIC AGENTS.
    HUMPHRIES SV.
    S Afr Med J; 1964 Apr 25; 38():276-8. PubMed ID: 14147352
    [No Abstract] [Full Text] [Related]

  • 24. INTENSIVE NITROGEN MUSTARD THERAPY WITH ABDOMINAL AORTIC OCCLUSION IN NASOPHARYNGEAL CARCINOMA.
    CLIFFORD P, BHARDWAJ BV, WHITTAKER LR.
    Br J Cancer; 1965 Mar 25; 19(1):51-71. PubMed ID: 14289054
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Protection against systemic toxicity due to nitrogen mustard.
    ROSS CA, CAR BERRY DM, KRAUS GE.
    Surg Forum; 1960 Mar 25; 11():43-5. PubMed ID: 13743580
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. PRELIMINARY DATA ON REGIONAL CHEMOTHERAPY OF MALIGNANT TUMOURS OF THE EXTREMITIES BY PERFUSION.
    TRAPEZNIKOV NN, AVDEEVA IA.
    Acta Unio Int Contra Cancrum; 1964 Mar 25; 20():462-4. PubMed ID: 14151960
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. L-PHENYLALANINE MUSTARD AS A TREATMENT FOR METASTATIC OSTEOGENIC SARCOMA IN CHILDREN.
    SULLIVAN MP, SUTOW WW, TAYLOR G.
    J Pediatr; 1963 Aug 25; 63():227-37. PubMed ID: 14043064
    [No Abstract] [Full Text] [Related]

  • 37. Enzyme alterable alkylating agents. XI. Clinical trials of an esterase-susceptible water-soluble agent (S-73) for regional chemotherapy.
    Bakal D, Goodman LE, Ulfohn A, Mamaril AG, Caplan YH, Calle S, Bhagavan BS, Witten B, Williamson CE, Sass S, Seligman AM.
    J Surg Res; 1971 May 25; 11(5):217-23. PubMed ID: 5090338
    [No Abstract] [Full Text] [Related]

  • 38. BRONCHIAL ARTERY INFUSION THERAPY OF LUNG NEOPLASMS WITH NITROGEN MUSTARD.
    SODERBERG CH, COLBERT MP, LEONE LA.
    Surgery; 1964 Nov 25; 56():897-904. PubMed ID: 14224585
    [No Abstract] [Full Text] [Related]

  • 39. FURTHER EXPERIENCE WITH COMBINED CYTOTOXIC THERAPY IN BRONCHIAL CARCINOMA.
    FELSTEIN IL.
    Br J Clin Pract; 1963 Oct 25; 17():578-80. PubMed ID: 14066114
    [No Abstract] [Full Text] [Related]

  • 40. CYTOTOXIC ACTIVITY COMPARED WITH PHOTOMETRIC MEASUREMENTS OF SELECTED ALKYLATING AGENTS.
    SANDERSON RP, MCKENNA JM, BLAKEMORE WS.
    Nature; 1965 Jan 30; 205():479-81. PubMed ID: 14265292
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.